Dr. Michael Chambers Elected Chairman of ProUroCare Board of Directors

ProUroCare Medical Inc., announced that current director Dr. Michael Chambers, JD, Ph.D., has been named Chairman of its Board of Directors. Dr. Chambers is an experienced businessman, entrepreneur and attorney. Dr. Chambers currently serves as President and CEO of Swift Biotechnology, a company he founded that is developing screens and diagnostics for ovarian and endometrial cancer in collaboration with the Mitchell Cancer Institute at the University of South Alabama.

Click here for more info.

NIH Awards $1.1M Grant to Mitchell Cancer Institute

The National Institute of Health (“NIH”) in Washington, D.C. has announced a grant of $1.1M to support Dr. Lewis J. Pannell’s work on an early stage screening test for ovarian cancer at the Mitchell Cancer Institute (“MCI”) and the University of South Alabama. Dr. Pannell is a professor of Oncologic Sciences, as well as head of the Proteomics and Mass Spectrometry Laboratory at MCI. Dr. Pannell previously worked for over 20 years as a senior investigator at NIH specializing in proteomics and biomarker research.

continue reading →

The Laura Crandall Brown Ovarian Cancer Foundation

May 2012: 
The Laura Crandall Brown Ovarian Cancer Foundation of Birmingham has awarded a $50,000 grant to support the work of Dr. Rodney Rocconi at the Mitchell Cancer Institute who is teaming with Swift Biotechnology to develop a screen to ensure early detection of ovarian cancer.

continue reading →

Gene Capture, recently announced that Dr. Michael Chambers of Swift Biotech, has been named to its Board of Directors.

Gene Capture, recently announced that Dr. Michael Chambers of Swift Biotech, has been named to its Board of Directors. Using a patented DNA hybridization process Gene Capture is developing a portable medical device to detect and identify target pathogens (such as infections diagnosed in hospitals) in less than 1 hour.

The Biotechnology Association of Alabama recently selected Dr. Michael Chambers of Swift Biotechnology, to membership in its Board of Directors.

The Biotechnology Association of Alabama recently selected Dr. Michael Chambers of Swift Biotechnology, to membership in its Board of Directors.  The Biotechnology Association of Alabama is a statewide organization representing Alabama’s bio related industries, research scientists, clinicians and business professionals who are working together to foster, develop and support the life sciences in Alabama.

InQBio Sciences, based in Huntsville, Alabama, recently announced that Dr. Michael Chambers of Swift Biotech, has been selected to its Board of Directors.

InQ Biosciences provides the first fully integrated cell growth and cell analysis system that combines a dynamic software-controlled sample environment with powerful imaging and real-time data collection. The InQ cell research system’s exclusive ability to control environmental parameters with correlated real-time sample feedback empowers researchers with astonishingly novel and efficient approaches to discovery.

ProUroCare (PUMD:NASDAQ), based in Minneapolis, Minnesota, announced that Dr. Michael Chambers has been named to its Board of Directors.

ProUroCare (PUMD:NASDAQ), based in Minneapolis, Minnesota, announced that Dr. Michael Chambers has been named to its Board of Directors.  Dr. Chambers is the President and CEO of Swift Biotech. Our The ProUroScanTM prostate imaging systemwas designed to produce an elasticity image of the prostate as an adjunctive aid in visualizing and documenting abnormalities in the prostate that have been detected by digital rectal examination.  The system’s breakthrough technology provides cost-effective, high-quality images in real-time.